Evidence map›Paper›PMID 23267019›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2013

Nck recruitment to the TCR required for ZAP70 activation during thymic development.

Aldo Borroto, Irene Arellano, Elaine P Dopfer, Marek Prouza, Miloslav Suchànek, Manuel Fuentes, Alberto Orfao, Wolfgang W Schamel, Balbino Alarcón

2 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
5.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05218434 phase1completednot on this mapstarted 2021, after this paper: background citation

A Randomised, Double-blind, Placebo-controlled, Study of the Safety, Tolerability, and Pharmacokinetics of AX-158 Following Administration of Single and, Multiple Ascending Oral Doses and Food Effect Sub-study in Healthy Male Volunteers

TypeinterventionalSponsorArtax Biopharma IncRan2021 to 2022Enrolled64ConditionsAutoimmune DiseasesArmsAX-158
NCT05725057 phase1 / phase2completednot on this mapstarted 2023, after this paper: background citation

A Phase 2a, Proof of Concept Study Evaluating the Safety and Tolerability of AX-158 in Patients With Mild to Moderate Plaque Psoriasis

TypeinterventionalSponsorArtax Biopharma IncRan2023 to 2024Enrolled31ConditionsPsoriasis, Plaque PsoriasisArmsAX-158, Placebo
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 34 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. A set point in the selection of the αβTCR T cell repertoire imposed by pre-TCR signaling strength.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Aldo BorrotoCentro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas, Universidad Autónoma de Madrid, Cantoblanco, Madrid 28049, Spain.
Irene Arellano
Elaine P Dopfer
Marek Prouza
Miloslav Suchànek
Manuel Fuentes
Alberto Orfao
Wolfgang W Schamel
Balbino Alarcón
Consejo Superior de Investigaciones Científicas · ESExbio (Czechia) · CZUniversity of Freiburg · DECentro de Biología Molecular Severo Ochoa · ESCentro de Investigación del Cáncer · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The adaptor protein Nck is inducibly recruited through its SH3.1 domain to a proline-rich sequence (PRS) in CD3ε after TCR engagement. However, experiments with a knockin mutant bearing an 8-aa replacement of the PRS have indicated that Nck binding to the TCR is constitutive, and that it promotes the degradation of the TCR in preselection double-positive (DP) CD4(+)CD8(+) thymocytes. To clarify these discrepancies, we have generated a new knockin mouse line (KI-PRS) bearing a conservative mutation in the PRS resulting from the replacement of the two central prolines. Thymocytes of KI-PRS mice are partly arrested at each step at which pre-TCR or TCR signaling is required. The mutation prevents the trigger-dependent inducible recruitment of endogenous Nck to the TCR but does not impair TCR degradation. However, KI-PRS preselection DP thymocytes show impaired tyrosine phosphorylation of CD3ζ, as well as impaired recruitment of ZAP70 to the TCR and impaired ZAP70 activation. Our results indicate that Nck is recruited to the TCR in an inducible manner in DP thymocytes, and that this recruitment is required for the activation of early TCR-dependent events. Differences in the extent of PRS mutation could explain the phenotypic differences in both knockin mice.

Indexed as

Adaptor Proteins, Signal TransducingAmino Acid SequenceAmino Acid SubstitutionAnimalsAntigen PresentationCD3 ComplexCD4 AntigensCD8 AntigensChlorocebus aethiopsCOS CellsEnzyme ActivationFemaleGene Knock-In TechniquesHydrophobic and Hydrophilic InteractionsLymphopoiesisMaleAdaptor Proteins, Signal TransducingCD3 ComplexCd3e protein, mouseCD4 AntigensCD8 AntigensNck proteinOncogene ProteinsReceptors, Antigen, T-Cell, alpha-betaRecombinant Fusion ProteinsZap70 protein, mouseZAP-70 Protein-Tyrosine Kinase

Identifiers

PMID23267019
PMCPMC3549223
OpenAlexW2164768254

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.